Filter
522
Filtered Results: 522
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
75
New Publications
104
Language
Document type
No document type
229
Guidelines
139
Studies & Reports
68
Manuals
49
Fact sheets
16
Strategic & Response Plan
13
Training Material
5
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
25
Germany
15
Global
12
Latin America and the Carribbean
12
South Africa
11
Western and Central Europe
10
Africa
9
Kenya
7
Russia
7
Tanzania
6
Rwanda
5
Brazil
5
Ethiopia
5
Sierra Leone
4
Cameroon
4
Nigeria
4
Eastern Europe
4
Namibia
4
Nepal
3
Senegal
3
Congo-Brazzaville
3
Burkina Faso
3
Malawi
3
West and Central Africa
3
Uganda
3
Zambia
3
Ukraine
2
Benin
2
Togo
2
Niger
2
Haiti
2
Asia
2
Venezuela
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
France
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Bangladesh
2
Mali
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Turkey
1
Gambia
1
Chile
1
Syria
1
Albania
1
Canada
1
Laos
1
Burundi
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
USA
1
South–East Asia Region
1
Luxembourg
1
North America
1
Belgium
1
Bolivia
1
Djibouti
1
Yemen
1
Angola
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
119
Clinical Guidelines
104
Pharmacy & Technologies
39
Public Health
16
Women & Child Health
16
Key Resources
10
Toolboxes
TB
72
COVID-19
69
HIV
65
NTDs
43
AMR
32
Rapid Response
22
Pharmacy
16
Refugee
12
Ebola & Marburg
12
Zika
12
Malaria
11
Mental Health
9
Caregiver
8
Polio
6
Planetary Health
4
Global Health Education
3
Cholera
2
Specific Hazards
1
Natural Hazards
1
Health Financing Toolbox
1
NCDs
1
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
3rd Edition – July 2017
www.msfaccess.org
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
The document provides a detailed overview of cholera, including its clinical features, diagnosis, treatment, and prevention. It explains the causes of cholera, its symptoms such as severe diarrhea and dehydration, and the importance of rehydration therapy (oral or intravenous) to reduce mortality. T...
Protocol and preliminary evaluationas of Jan 17, 2020
This manual is to assist health care providers and laboratory scientists to diagnose mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the clinical presentation and its diagnosis. The methods described are tailored to various levels of care and avail...
Eur Respir J 2016; 48: 808–817 | DOI: 10.1183/13993003.00840-2016
The Global Schistosomiasis Alliance Diagnostic Workstream has developed a communications piece listing all commercially available diagnostics for schistosomiasis
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
Jin et al. Military Medical Research (2020) 7:4 https://doi.org/10.1186/s40779-020-0233-6
Position Article und Guideline
Lignes directrices.
Collection Avis et Rapports.
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
